Guo et al. first reported that Nedd4l-CTR1 regulates AKT kinase in a copper/PDK1-binding manner, and emphasized that AKT-driven destruction of tumor cells can be achieved by targeting the CTR1/copper-signaling pathway 15. This evidence concerns the gene PDK1 and neoplasm.